Cargando…

Sociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A Population-Based Study

BACKGROUND: In the Netherlands, lower high-risk human papillomavirus (hrHPV) positivity but higher cervical intraepithelial neoplasia (CIN) 2+ detection were found in self-collected compared with clinician-collected samples. To investigate the possible reason for these differences, we compared socio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aitken, Clare A., Inturrisi, Federica, Kaljouw, Sylvia, Nieboer, Daan, Siebers, Albert G., Melchers, Willem J.G., van den Brule, Adriaan J.C., Molijn, Anco, Hinrichs, John W.J., Niesters, Hubert G.M., van Kemenade, Folkert J., Berkhof, Johannes, de Kok, Inge M.C.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900317/ https://www.ncbi.nlm.nih.gov/pubmed/36099416 http://dx.doi.org/10.1158/1055-9965.EPI-22-0712

Ejemplares similares

Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
por: Inturrisi, Federica, et al.
Publicado: (2021)

Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
por: Aitken, Clare A., et al.
Publicado: (2019)

Investigating the decrease in participation in the Dutch cervical cancer screening programme: The role of personal and organisational characteristics
por: Aitken, Clare A., et al.
Publicado: (2021)

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV‐positive women: Results from a Dutch primary HPV‐based screening cohort
por: Verhoef, Lisanne, et al.
Publicado: (2021)

Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening
por: Verhoef, Lisanne, et al.
Publicado: (2023)

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening
por: Aitken, Clare A, et al.
Publicado: (2019)

A second generation cervico-vaginal lavage device shows similar performance as its preceding version with respect to DNA yield and HPV DNA results
por: Verhoef, Viola MJ, et al.
Publicado: (2013)

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands
por: Schurink‐van ’t Klooster, Tessa M., et al.
Publicado: (2023)

Reflex cytology for triage of high‐risk human papillomavirus positive self‐sampled material in cervical cancer screening: a prospective cohort study
por: Loopik, DL, et al.
Publicado: (2020)

HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study
por: Gök, Murat, et al.
Publicado: (2010)

Cervical intraepithelial neoplasia and the risk of spontaneous preterm birth: A Dutch population-based cohort study with 45,259 pregnancy outcomes
por: Loopik, Diede L., et al.
Publicado: (2021)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

Identification of over- and undertreatment in the Dutch national cervical cancer screening program: A data linkage study at the hospital level
por: Vink, Maarten D., et al.
Publicado: (2023)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

Shift in harms and benefits of cervical cancer screening in the era of HPV screening and vaccination: a modelling study
por: Kaljouw, Sylvia, et al.
Publicado: (2022)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
por: Rijkaart, D C, et al.
Publicado: (2012)

Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study
por: Inturrisi, Federica, et al.
Publicado: (2022)

Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study
por: Ebisch, Renée M. F., et al.
Publicado: (2018)

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
por: Kooyker, Arthur I., et al.
Publicado: (2020)

Comparing the sensitivities of two screening tests in nonblinded randomized paired screen‐positive trials with differential screening uptake
por: van de Ven, Peter M., et al.
Publicado: (2021)

The effect of extended participation windows on attendance at cervical cancer screening
por: Castañeda, Kelly M., et al.
Publicado: (2023)

The emergence of enterovirus D68 in a Dutch University Medical Center and the necessity for routinely screening for respiratory viruses
por: Poelman, Randy, et al.
Publicado: (2015)

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency
por: Bulk, S, et al.
Publicado: (2007)

Acceptability of risk-based triage in cervical cancer screening: A focus group study
por: Bas, Sharell, et al.
Publicado: (2023)

The added value of digital imaging to reflex cytology for triage of high‐risk human papillomavirus positive self‐sampled material in cervical cancer screening: A prospective cohort study
por: Wiersma, Danique, et al.
Publicado: (2022)

Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2023)

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test
por: Rijkaart, D C, et al.
Publicado: (2010)

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates
por: Rozemeijer, Kirsten, et al.
Publicado: (2015)

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
por: De Strooper, Lise M.A., et al.
Publicado: (2016)

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology‐screened referral population
por: Leeman, Annemiek, et al.
Publicado: (2018)

Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing
por: van der Meulen, Miriam P., et al.
Publicado: (2022)

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2019)

Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy
por: Aitken, Clare A., et al.
Publicado: (2019)

Cascade Screening for Familial Hypercholesterolemia (FH)
por: Ned, Renée M., et al.
Publicado: (2011)

Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT‐based CRC screening program
por: Breekveldt, Emilie C. H., et al.
Publicado: (2022)

Clinical virology in real time
por: Niesters, Hubert G.M
Publicado: (2002)

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases
por: Gök, M, et al.
Publicado: (2011)

Resilience of a FIT screening programme against screening fatigue: a modelling study
por: Greuter, Marjolein J. E., et al.
Publicado: (2016)

Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high‐risk human papillomavirus‐positive population
por: Ebisch, Renée M. F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ald7kajfp007941de9jc5442ju